Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,107,024
-$357,978 QoQ
Shares Held
87,501
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#937
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Iowa State Bank holds $35,695,888 across 7 Drug Manufacturers - General names. PFE ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
45,266 | $11,390,736 | |
| 2 | JNJ |
Johnson & Johnson
|
33,394 | $8,481,074 | |
| 3 | LLY |
ELI LILLY & Co
|
5,120 | $6,141,082 | |
| 4 | AMGN |
Amgen Inc
|
9,653 | $3,495,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
18,782 | $2,372,917 | |
| 6 | PFE |
Pfizer Inc
This page
|
87,501 | $2,107,024 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,634 | $1,707,511 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,107,024 | 87,501 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,465,002 | 87,785 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,222,524 | 89,258 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $2,376,060 | 93,252 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $2,270,172 | 93,654 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,413,787 | 95,256 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,519,739 | 94,977 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $2,761,541 | 95,423 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,682,442 | 95,870 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,162,113 | 77,914 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,887,176 | 100,284 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $5,997,633 | 180,815 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $6,711,632 | 182,978 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $7,901,041 | 193,653 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $10,289,042 | 200,801 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $8,584,530 | 196,173 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $10,496,118 | 200,193 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $10,300,210 | 198,961 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $12,088,774 | 204,721 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $8,105,965 | 188,467 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $7,303,182 | 186,496 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $6,721,280 | 185,517 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $6,262,999 | 170,144 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $5,915,849 | 161,195 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,549,784 | 139,137 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $5,089,352 | 155,924 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||